Search results for: 'rail chemical ad biologics testing'

10 May 2023  |  Global  |  Market Research

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

Infographics

×

This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

24 May 2023  |  Global  |  Market Research

The Impact of Regulations on the Chemical Industry

New Chemicals Regulations will Create Growth Opportunities Through New Product Development and Advanced Technology Strategies

Infographics

×

This study analyzes the key regulations in the chemical industry and examines how various stakeholders are responding to the changing regulatory landscape. It serves as a regulatory handbook and helps understand how regulations have been evolving in the chemical industry. With regulatory authorities increasingly responding to the rising concerns ov...

The analysis covers a portfolio of import-dependent chemical intermediates and downstream derivatives in India. The growth opportunities are categorized into three strategic buckets namely, scalable opportunities, conditional bets, and plausible MOAT. Each consists of chemical intermediates filtered based on import scale, balanced import source, In...

Dips and sags from power delivery inconsistencies can harm devices, causing inconvenient and expensive consequences. A move towards din rail surge protection devices (SPD) is seen as real estate becomes a critical part of systems. The US din rail SPD market is gaining momentum and shows growth potential, but in the interim it is heavily dominated b...

This study analyzes the impact of evolving regulatory frameworks across the chemical industry, focusing on both product-level and end-industry regulations. The scope spans key product segments including coatings, adhesives and sealants, polymers and composites, fuels and lubricants, and process chemicals, while also assessing downstream implication...

Electronic chemicals constitute a foundational input to semiconductor, printed circuit board (PCB), and flat panel display (FPD) manufacturing, underpinning the precision, purity, and performance requirements of increasingly sophisticated electronic devices. This study presents a comprehensive analysis of the global electronic chemicals market, enc...

05 Sep 2022  |  Global  |  Market Research

Global Agricultural Biologicals Market, Forecast to 2030

Changes in Regulatory Environment to Fuel Growth Opportunities in the Biopesticides and Biostimulants Sectors

Infographics

×

Key Issues Addressed

This research service provides qualitative and quantitative analyses of agricultural biologicals by segment: biopesticides and biostimulants. The biopesticides segment is divided by type (bioherbicides, bioinsecticides, biofungicides, and bionematicides) and by source (microbials and biochemicals). The biostimulants segment is divided only by typ...

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...